Utility of High Flow Nasal Cannula during Pulmonary Rehabilitation in COVID-19 Patients in Acute Respiratory Failure
Source abstract
Abstract
High-flow nasal cannula (HFNC) has often been used in the treatment of acute respiratory failure during pulmonary rehabilitation setting. The aim of this retrospective study was to investigate the utility of HCFN during the early rehabilitation in COVID-19 pneumonia. Twenty-two patients (10 males and 12 females, mean age 64.5 ± 5.9 years) with COVID-19 pneumonia were considered. Medical data and rehabilitative scales were used to evaluate acute hypoxemic respiratory failure (PaO2/FiO2 < 300), treated with HFNC three times during evaluation. Overall clinical outcomes from the evaluation of the synergy between HFNC strategy and rehabilitation were evaluated. A statistically significant improvement was observed at T2 (and of treatment) in 1 minute sit to stand test (1STST) (4 ± 3 vs. 17 ± 5, p < 0.05), short physical performance battery (SPPB) (4.3 ± 2.81 vs. 9.15 ± 2.39, p < 0.05), SpO2% post effort (93 ± 1.26 vs. 98 ± 1.01, p < 0.05), respiratory rate post effort (RR) (24 ± 3.91 vs. 20 ± 3.13, p < 0.05), heart rate (HR) (97 ± 11.9 vs. 87 ± 9.17, p < 0.05), P/F rate (235 ± 7.35 vs. 331 ± 10.91, p < 0.05), SpO2 (86 ± 4.54 vs. 97 ± 1.01 p < 0.05), RR (20 ± 4 vs. 12 ± 1.39, p < 0.05). Then, treated HFNC patients showed a good improvement in physical performance at T2 and a good compliance with treatments proved to be extremely useful in the control and reduction of dyspnea and fatigue symptoms.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Long-Term Effects of COVID-19 · Respiratory Support and Mechanisms · Intensive Care Unit Cognitive Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Physical Medicine and Rehabilitation, Department of Oral, Medical and Biotechnological Sciences (DSMOB), University G. D’Annunzio of Chieti, 66100 Chieti, Italy
Physical Medicine and Rehabilitation Unit, Pescara General Hospital, 66020 Pescara, Italy
Infectious Disease Unit, Pescara General Hospital, 66020 Pescara, Italy
Pulmonary Medicine Unit, Pescara General Hospital, 66020 Pescara, Italy
Physical Medicine and Rehabilitation, Santo Spirito Hospital, 00193 Rome, Italy
References (31)
Show source-provided references
1. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)10.1016/j.ijsu.2020.02.034 ↗
2. COVID-19 Lombardia ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy10.1001/jama.2020.5394 ↗
3. the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area10.1001/jama.2020.6775 ↗
4. Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterization Protocol: Prospective observational cohort study
5. Intensive care management of patients with COVID-19: A practical approach10.1186/s13613-021-00820-w ↗
6. Clinical course recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection
7. Treatment for severe acute respiratory distress syndrome from COVID-1910.1016/S2213-2600(20)30127-2 ↗
8. Use of nasal high flow oxygen during acute respiratory failure10.1007/s00134-020-06228-7 ↗
9. High flow nasal cannula oxygen therapy to treat patient with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection10.1136/thoraxjnl-2020-214993 ↗
10. High-Flow Nasal Cannula and COVID-19: A Clinical Review10.4187/respcare.09056 ↗
11. Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: A randomized clinical trial10.1001/jama.2016.2711 ↗
12. Complex effects of high-flow nasal cannula therapy on hemodynamics in the pediatric patient after cardiac surgery10.1186/s40560-017-0227-y ↗
13. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: Effects of increasing flow rates10.1007/s00134-017-4890-1 ↗
14. Effects of nasal high flow on ventilation in volunteers, COPD, and idiopathic pulmonary fibrosis patients10.1159/000342027 ↗
15. The High Flow Nasal Cannula Improves the Exercise Capacity in Patients with Chronic Obstructive Pulmonary Disease: Randomized, Crossover Clinical Trial
16. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalization10.1183/13993003.02096-2020 ↗
17. Functional outcome after inpatient rehabilitation in postintensive care unit COVID-19 patients: Findings and clinical implications from a real-practice retrospective study10.23736/S1973-9087.20.06660-5 ↗
18. La kinésithérapie respiratoire du poumon profond. Bases mécaniques d’un nouveau paradigme [Chest physical therapy of the distal lung. Mechanical basis of a new paradigm]10.1016/j.rmr.2013.11.009 ↗
19. Outcome measures in cardiopulmonary physical therapy: SPPB10.1097/01823246-200819010-00005 ↗
20. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission10.1093/geronj/49.2.M85 ↗
21. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability10.1056/NEJM199503023320902 ↗
22. 1-Minute sit-to-stand test: Systematic review of procedures, performance, and clinimetric properties10.1097/HCR.0000000000000336 ↗
23. Assessment of dyspnea in COVID-19 patients using modified borg scale10.22514/sv.2021.182 ↗
24. Efficiency of High-Flow Nasal Cannula on Pulmonary Rehabilitation in COPD Patients: A Meta-Analysis10.1155/2020/7097243 ↗
25. The efficacy and safety of high-flow nasal cannula therapy in patients with COPD and type II respiratory failure: A meta-analysis and systematic review10.1186/s40001-021-00587-7 ↗
26. COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problems10.1016/j.pulmoe.2020.04.013 ↗
27. Personalised pulmonary rehabilitation in COPD10.1183/16000617.0125-2017 ↗
28. Recommendations for respiratory rehabilitation in adults with coronavirus disease 201910.1097/CM9.0000000000000848 ↗
29. Bonnesen, B., Jensen, J.S., Jeschke, K.N., Mathioudakis, A.G., Corlateanu, A., Hansen, E.F., Weinreich, U.M., Hilberg, O., and Sivapalan, P. (2021). Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation. Diagnostics, 11.10.3390/diagnostics11122259 ↗
30. Jimeno-Almazán, A., Pallarés, J.G., Buendía-Romero, Á., Martínez-Cava, A., Franco-López, F., Martínez, B.J.S.-A., Bernal-Morel, E., and Courel-Ibáñez, J. (2021). Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int. J. Environ. Res. Public Health, 18.10.3390/ijerph18105329 ↗
31. Supervised Exercise (Vivifrail) Protects Institutionalized Older Adults Against Severe Functional Decline After 14 Weeks of COVID Confinement10.1016/j.jamda.2020.11.007 ↗